Quick Takeaways
- Jose Carmona has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,930,160.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jose Carmona
- Location
- Newtown Square, PA
- Summary
- The estimated net worth of Jose Carmona is at least $2,930,160 dollars as of 18 Feb 2026. Jose Carmona is the Chief Financial Officer of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $2.93M.
- Signature
- /s/ Lisa Kallebo, Attorney-in-Fact for Jose Carmona
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jose Carmona and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: ADC Therapeutics SA ($2,930,160).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jose Carmona
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | Chief Financial Officer | $2,930,160 | 13 Feb 2026 | ||
| RUBY | Rubius Therapeutics, Inc. | Chief Financial Officer | 31 Jan 2022 |
Insider Transactions Reported by Jose Carmona:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.